Search results for "depression"

showing 10 items of 1778 documents

Early Improvement and Serum Concentrations of Citalopram to Predict Antidepressant Drug Response of Patients with Major Depression

2013

Post hoc analyses of clinical trials have shown that early improvement around day 14 is highly predictive for later response. More- over, evidence has been given that suffi ciently high concentrations of antidepressant drugs in blood are required to attain response. In this study, we determined cut-off levels for citalo- pram serum concentrations and clinical improve- ment during the early phase of treatment to predict later response and the predictive power of these measures either alone or in combination. Methods: Inpatients with depressive disorder according to ICD-10 who received citalopram were included. Psychopathology was assessed by the 17-item Hamilton Depression (HAMD-17) rating s…

Malemedicine.medical_specialtyCitalopramCitalopramSensitivity and SpecificityPredictive Value of TestsRating scaleInternal medicinemedicineHumansPharmacology (medical)Depression (differential diagnoses)Depressive Disorder MajorReceiver operating characteristicGeneral MedicineOdds ratioMiddle AgedAntidepressive AgentsClinical trialPsychiatry and Mental healthAnesthesiaAntidepressantFemalePsychologyPsychopathologymedicine.drugPharmacopsychiatry
researchProduct

Non-competitive inhibition of clomipramineN-demethylation by fluvoxamine

1995

The selective serotonin reuptake inhibitor fluvoxamine interferes with the metabolism of tricyclic antidepressants. The present investigation was set out to characterize these interactions in vitro using rat liver microsomes and in vivo by analysing levels of clomipramine and metabolites in sera of depressed patients treated concomitantly with fluvoxamine and clomipramine. Clomipramine was N-demethylated and hydroxylated in vitro by microsomes to N-desmethyl-clomipramine, 8-hydroxyclomipramine, and 10-hydroxyclomipramine. Kinetic analyses revealed Km values of 6.2 microM for N-demethylation and 1.2 microM for 8-hydroxylation. Fluvoxamine was a non-competitive inhibitor for N-demethylation w…

Malemedicine.medical_specialtyClomipramineSerotonin reuptake inhibitorFluvoxamineIn Vitro TechniquesPharmacologyHydroxylationRats Sprague-DawleyPharmacokineticsInternal medicinemedicineAnimalsHumansPharmacologychemistry.chemical_classificationDrug interactionRatsEndocrinologychemistryDealkylationFluvoxamineDepression ChemicalClomipramineMicrosomes LiverSerotoninReuptake inhibitormedicine.drugTricyclicPsychopharmacology
researchProduct

Relevance of depression for anticoagulation management in a routine medical care setting: results from the ThrombEVAL study program

2014

Summary Background Depressive symptoms have detrimental effects on quality of life and mortality. Poor adherence to a treatment regimen is a potential mechanism for the increased risk of adverse medical events associated with depression. Regarding oral anticoagulation with vitamin K antagonists, adherence is crucial for the outcome. Little is known about the clinical relevance of current depressiveness for anticoagulation treatment. Objectives To examine the impact of current depressiveness on anticoagulation treatment in regular medical care. Patients/Methods We examined the association between clinically significant depressiveness as assessed by the Patient Health Questionnaire-2 ≥ 2 (PHQ…

Malemedicine.medical_specialtyCross-sectional studyAdministration OralHealth literacyMedication AdherenceCohort StudiesPatient satisfactionQuality of lifeAmbulatory careSurveys and QuestionnairesInternal medicineAmbulatory CarePrevalenceHumansMedicineClinical significanceInternational Normalized RatioDepression (differential diagnoses)AgedDepressionbusiness.industryAnticoagulantsHematologyMiddle AgedCross-Sectional StudiesTreatment OutcomePatient SatisfactionMultivariate AnalysisPhenprocoumonQuality of LifePhysical therapyFemalebusinessCohort studyJournal of Thrombosis and Haemostasis
researchProduct

Comorbidity between depressive symptoms and migraine: preliminary data from the Zabút Aging Project

2008

We evaluated the association between depressive symptoms and migraine using cross-sectional data from the Zabút Aging Project, a population-based study including subjects agedor =50 years. A total of 1285 nonmigraineurs and 151 migraineurs were included. Diagnosis of migraine was carried out using the criteria of the International Headache Society. The Center for Epidemiologic Studies Depression scale (CES-D) was used to score depressive symptoms. Depressive symptoms were clustered in four groups: depressed and positive affects, somatic activity and intrapersonal feelings. Migraineurs showed higher total and specific depressive symptoms than controls (p from 0.005 to0.0001). Mild-to-moderat…

Malemedicine.medical_specialtyCross-sectional studyMigraine DisordersPopulationDermatologyCommunity Health PlanningInternal medicineEpidemiologyOdds RatiomedicineHumansPsychiatryeducationGeriatric AssessmentDepression (differential diagnoses)AgedAged 80 and overMigraine Epidemiology Depression Elderlyeducation.field_of_studyDepressionbusiness.industryGeneral MedicineOdds ratioMiddle AgedCenter for Epidemiologic Studies Depression Scalemedicine.diseaseComorbidityPsychiatry and Mental healthCross-Sectional StudiesMigraineFemaleSettore MED/26 - NeurologiaNeurology (clinical)businessNeurological Sciences
researchProduct

Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications

2019

Abstract Background Migraine is a highly prevalent and disabling neurological disorder which is commonly linked with a broad range of psychiatric comorbidities, especially among subjects with migraine with aura or chronic migraine. Defining the exact nature of the association between migraine and psychiatric disorders and bringing out the pathophysiological mechanisms underlying the comorbidity with psychiatric conditions are relevant issues in the clinical practice. Methods A systematic review of the most relevant studies about migraine and psychiatric comorbidity was performed using “PubMed”, “Scopus”, and “ScienceDirect” electronic databases from 1 January 1998 to 15 July 2018. Overall, …

Malemedicine.medical_specialtyDatabases Factualbiological pathways; comorbidity; migraine; psychiatric disordersMigraine DisordersBiological pathwayslcsh:MedicineNeurological disorderReview ArticleComorbidityBiological pathways; Comorbidity; Migraine; Psychiatric disorders; Comorbidity; Databases Factual; Depressive Disorder Major; Disabled Persons; Female; Humans; Male; Mental Disorders; Migraine Disorders; Prevalence; Treatment Outcome03 medical and health sciencesDatabases0302 clinical medicineChronic MigrainemedicinePrevalenceHumansDisabled Persons030212 general & internal medicinePsychiatryDepression (differential diagnoses)FactualMigraineDepressive Disorder MajorDepressive Disorderbusiness.industryPanic disorderMental Disorderslcsh:RMajorGeneral Medicinemedicine.diseaseComorbidityMigraine with auraAnesthesiology and Pain MedicineTreatment OutcomeMigraineFemaleNeurology (clinical)medicine.symptombusinessPsychiatric disordersPsychosocial030217 neurology & neurosurgery
researchProduct

Physical activity and depression: type of exercise matters.

2015

Letter to the editor 9.528 JCR (2015) Q1, 1/120 Pediatrics UEM

Malemedicine.medical_specialtyDepressive Disorder Majorbusiness.industryDepressionDepresión mentalPhysical activityMEDLINEMotor ActivityPediatrics Perinatology and Child HealthMedicineHumansFemaleExercise physiologybusinessPsychiatryEducación físicaExerciseDepression (differential diagnoses)JAMA pediatrics
researchProduct

Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease

2020

BACKGROUND AND AIM: Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent chronic liver disease. Its role in the development of extrahepatic co-morbidities is under investigation. The impact of NAFLD on the development of chronic kidney disease (CKD) is incompletely understood. The aim of this study was to explore the potential contribution of NAFLD on CKD in Germany. METHODS: The Disease Analyzer Database covering 7.49 million cases in Germany was explored for patients diagnosed with NAFLD between 2000 and 2015 and was matched 1:1 to a cohort without NAFLD. Matching criteria included age, sex, physician, index year and co-diagnoses associated with CKD. The primary outcomes of thi…

Malemedicine.medical_specialtyDiseaseComorbidityChronic liver diseaseGastroenterologydigestive systemNon-alcoholic Fatty Liver DiseaseRisk FactorsInternal medicineGermanymedicineHumansRenal Insufficiency ChronicDepression (differential diagnoses)AgedProportional Hazards ModelsRetrospective Studiesbusiness.industryIncidenceFatty liverGastroenterologynutritional and metabolic diseasesNon alcoholicMiddle Agedmedicine.diseasedigestive system diseasesOncologyFemaleHepatobiliaryMetabolic syndromebusinessAnxiety disorderKidney disease
researchProduct

Activation of a ΔFOSB dependent gene expression pattern in the dorsolateral prefrontal cortex of patients with major depressive disorder

2010

Abstract Background A ΔFOSB mediated transcriptional response in the nucleus accumbens (NAc) is induced by chronic social stress in rodent and a 50% down-regulation of ΔFOSB has been also reported in the NAc of eight depressed subjects. To evaluate the role of ΔFOSB in the prefrontal cortex which is critically involved in negative cognitive bias associated with major depressive disorder (MDD) we have quantified the mRNA levels of ΔFOSB and of five of its major target genes in the Brodmann area 46 from 24 patients with MDD (11 with psychotic symptoms) and 12 controls. Method Expression of the six genes has been quantified by a real-time quantitative PCR method: ΔFOSB , GRIA2 (encoding the Gl…

Malemedicine.medical_specialtyDown-RegulationGene ExpressionPrefrontal CortexNerve Tissue ProteinsAMPA receptorNucleus accumbensNucleus AccumbensInternal medicineBrodmann area 46medicineHumansReceptors AMPAGRIA2Prefrontal cortexAgedSecretogranin IIIDepressive DisorderDepressive Disorder MajorbiologyDepressionMiddle AgedAntidepressive AgentsDorsolateral prefrontal cortexPsychiatry and Mental healthClinical PsychologyEndocrinologymedicine.anatomical_structurePCP4Case-Control Studiesbiology.proteinFemalePsychologyProto-Oncogene Proteins c-fosNeuroscienceJournal of Affective Disorders
researchProduct

Association of Depressive Symptoms With Impaired Glucose Regulation, Screen-Detected, and Previously Known Type 2 Diabetes

2010

OBJECTIVE To study the association between impaired glucose regulation (IGR), screen-detected type 2 diabetes, and previously known diabetes and depressive symptoms. RESEARCH DESIGN AND METHODS Altogether, 2,712 participants from three hospital districts in Finland attended a health examination. Cutoff scores ≥10 and ≥16 in the 21-item Beck Depression Inventory (BDI-21) were used for depressive symptoms. The participants were defined as having known diabetes if they reported diabetes. An oral glucose tolerance test was used to detect normal glucose regulation (NGR), impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and screen-detected diabetes. The participants were defined…

Malemedicine.medical_specialtyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismType 2 diabetesImpaired glucose tolerance03 medical and health sciences0302 clinical medicineInternal medicineDiabetes mellitusGlucose IntoleranceInternal MedicinemedicineHumans030212 general & internal medicineEpidemiology/Health Services ResearchDepression (differential diagnoses)Original ResearchAgedAdvanced and Specialized NursingDepressionbusiness.industryBeck Depression InventoryOdds ratioMiddle Agedmedicine.diseaseImpaired fasting glucose3. Good healthLogistic ModelsEndocrinologyDiabetes Mellitus Type 2Multivariate AnalysisFemaleBlood sugar regulationbusinessDiabetes Care
researchProduct

Associations of NT-proBNP and parameters of mental health in depressed coronary artery disease patients

2018

Natriuretic peptides (NP) are involved in the regulation of blood pressure and blood volume, and are elevated in patients with coronary artery disease (CAD). They are used as markers for illness severity, but their role in mental health is not well understood. Recently, A-type NP (ANP) has been associated with reduced anxiety in studies on cardiac patients; however, this study is the first to assess this effect for B-type NP (BNP) and for further dimensions of well-being and mental health. Depression, anxiety, and distress are more common in CAD patients than in the general population and are most likely not only influenced by psychological adaptation but also by neurobiological processes. …

Malemedicine.medical_specialtyEndocrinology Diabetes and MetabolismCoronary Artery DiseaseAnxiety030204 cardiovascular system & hematologyHospital Anxiety and Depression ScaleSeverity of Illness IndexCoronary artery disease03 medical and health sciences0302 clinical medicineEndocrinologyRisk FactorsInternal medicineNatriuretic Peptide BrainSeverity of illnessHumansMedicinecardiovascular diseasesBiological PsychiatryAgedDepressive DisorderDepressionEndocrine and Autonomic Systemsbusiness.industryType D personalityMiddle Agedmedicine.diseaseMental healthPeptide Fragments3. Good healthPsychotherapyPsychiatry and Mental healthDistressMental HealthQuality of LifeAnxietyFemalemedicine.symptombusinessPsychosocialBiomarkers030217 neurology & neurosurgeryPsychoneuroendocrinology
researchProduct